TY - JOUR
T1 - β(2 → 1)-β(2 → 6) and β(2 → 1) fructans protect from impairment of intestinal tight junction's gene expression and attenuate human dendritic cell responses in a fructan-dependent fashion
AU - Fernández-Lainez, Cynthia
AU - aan de Stegge, Myrthe
AU - Silva-Lagos, Luis Alfredo
AU - López-Velázquez, Gabriel
AU - de Vos, Paul
N1 - Funding Information:
This study was partially financed by the “Programa de Recursos Fiscales para Investigación” from Instituto Nacional de Pediatría, Grant number 2019/062. C.F.L. was financially supported by Abel Tasman Talent Program Sandwich PhD from the University of Groningen-University Medical Center Groningen, UG/UMCG in collaboration with Universidad Nacional Autónoma de México, UNAM and CONACYT (#260625).
Funding Information:
This study was partially financed by the “Programa de Recursos Fiscales para Investigación” from Instituto Nacional de Pediatría , Grant number 2019/062 . C.F.L. was financially supported by Abel Tasman Talent Program Sandwich PhD from the University of Groningen - University Medical Center Groningen , UG/UMCG in collaboration with Universidad Nacional Autónoma de México , UNAM and CONACYT (# 260625 ).
Publisher Copyright:
© 2023 The Authors
PY - 2023/11/15
Y1 - 2023/11/15
N2 - β(2 → 1)-β(2 → 6) branched graminan-type fructans (GTFs) and β(2 → 1) linear fructans (ITFs) possess immunomodulatory properties and protect human intestinal barrier function, however the mechanisms underlying these effects are not well studied. Herein, GTFs and ITFs effects with different degree of polymerization (DP) values on tight junctions (TJs) genes CLDN-1, -2 and -3, CDH1, OCLN and TJP1 were studied in Caco-2 gut epithelial cells, under homeostatic and inflammatory conditions. Also, cytokine production in dendritic cells (DCs) was studied. Higher DP fructans decreased the expression of the pore forming CLDN-2. Higher DP GTFs enhanced CLDN-3, OCLN, and TJP-1. Fructans prevented mRNA dysregulation of CLDN-1, -2 and -3 induced by the barrier disruptors A23187 and deoxynivalenol in a fructan-type dependent fashion. The production of pro-inflammatory cytokines MCP-1/CCL2, MIP-1α/CCL3 and TNFα by DCs was also attenuated in a fructan-type dependent manner and was strongly attenuated by DCs cultured with medium of Caco-2 cells which were pre-exposed to fructans. Our data show that specific fructans have TJs and DCs modulating effects and contribute to gut homeostasis. This might serve to design effective dietary means to prevent intestinal inflammation.
AB - β(2 → 1)-β(2 → 6) branched graminan-type fructans (GTFs) and β(2 → 1) linear fructans (ITFs) possess immunomodulatory properties and protect human intestinal barrier function, however the mechanisms underlying these effects are not well studied. Herein, GTFs and ITFs effects with different degree of polymerization (DP) values on tight junctions (TJs) genes CLDN-1, -2 and -3, CDH1, OCLN and TJP1 were studied in Caco-2 gut epithelial cells, under homeostatic and inflammatory conditions. Also, cytokine production in dendritic cells (DCs) was studied. Higher DP fructans decreased the expression of the pore forming CLDN-2. Higher DP GTFs enhanced CLDN-3, OCLN, and TJP-1. Fructans prevented mRNA dysregulation of CLDN-1, -2 and -3 induced by the barrier disruptors A23187 and deoxynivalenol in a fructan-type dependent fashion. The production of pro-inflammatory cytokines MCP-1/CCL2, MIP-1α/CCL3 and TNFα by DCs was also attenuated in a fructan-type dependent manner and was strongly attenuated by DCs cultured with medium of Caco-2 cells which were pre-exposed to fructans. Our data show that specific fructans have TJs and DCs modulating effects and contribute to gut homeostasis. This might serve to design effective dietary means to prevent intestinal inflammation.
KW - Functional foods
KW - Inflammatory bowel disease
KW - Intestinal and immune cells crosstalk
KW - Non-digestible carbohydrates
KW - Nutraceuticals
KW - Tight junctions
U2 - 10.1016/j.carbpol.2023.121259
DO - 10.1016/j.carbpol.2023.121259
M3 - Article
C2 - 37659831
AN - SCOPUS:85169518791
SN - 0144-8617
VL - 320
JO - Carbohydrate Polymers
JF - Carbohydrate Polymers
M1 - 121259
ER -